Work

Abstract 6009: BGB-B2033, a novel 4-1BB/GPC3 bispecific antibody, exhibits potent in vitro and vivo antitumor activity in preclinical models

Year: 2025
Type: conference-abstract
Institution: BeiGene (China)
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4409631458
Cites:
Cited by: 1
Related to: 10